Temporary headache, flushing, or light-headedness shortly after administration
Aim for tissue adjacent to the injured area rather than the injury itself
When the administration of Liposomal Glutathione leads to the manifestation of intolerable adverse effects
The use of NNMT inhibitors as a potential obesity treatment has been investigated preclinically 8,9,13 , and observational clinical data suggests that increased NNMT expression and activity correlate with increased incidence of Type 2 diabetes (T2D) and risk of obesity, respectively 10,11
Ezatiostat), a GST P1-1 inhibitor, has been proposed as a promising approach to treat patients with myelodysplastic syndrome (72)
All of the ingredients used in IVs are manufactured or compounded in FDA-registered facilities under stringent quality control guidelines